Mostrando 6 resultados de: 6
Filtros aplicados
Subtipo de publicación
Article(6)
Publisher
Biotecnologia Aplicada(1)
Clinical and Translational Immunology(1)
Gerontology(1)
Immunity and Ageing(1)
International Immunopharmacology(1)
C-Phycocyanin ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells
ArticleAbstract: For decades Experimental Autoimmune Encephalitis (EAE) has remained as an unsurpassed multiple sclerPalabras claves:Central nervous system, Demyelination, Multiple Sclerosis, Neurodegenerative disorder, Regulatory T cellsAutores:Acosta-Medina E.F., Alexey Llópiz-Arzuaga, Alonso-Ramírez R., Cervantes-Llanos M., Falcón-Cama V., Guillén-Nieto G.E., Lagumersindez-Denis N., López-Saura P.A., Marín-Prida J., Martínez-Sánchez G., Pentón-Arias E., Pentón-Rol G., Rodríguez-Jiménez E., Valenzuela-Silva C.M.Fuentes:googlescopusAn anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients
ArticleAbstract: Background: Since the COVID-19 outbreak an unprecedented challenge for healthcare systems around thePalabras claves:covid-19, Cytokine release syndrome, IL-6, ItolizumabAutores:Añe-Kouri A.L., Betancourt J., Caballero A., Cepeda M., Chávez E., Filgueira L.M., Herrera C., Hidalgo C.J., Leon K., Lorenzo G., Manso L., Mazorra Z., Ramos M., Saavedra Hernández D., Sánchez N., Tania Crombet, Valenzuela-Silva C.M.Fuentes:scopusTreatment of COVID-19 patients with the anti-CD6 antibody itolizumab
ArticleAbstract: Objectives: COVID-19 can lead to a hyperinflammatory state. CD6 is a glycoprotein expressed on maturPalabras claves:CD6, covid-19, Cytokine release syndrome, Itolizumab, Monoclonal antibody, SARS-COV2Autores:Arencibia M., Betancourt J., Caballero A., Cabrera L., Castillo U., Cepeda M., Despaigne R.E., Diaz H., Domecq M., Escalona A., Estevez D., Filgueira L.M., García Y., Hidalgo C.J., Leon K., Lorenzo G., Lorenzo P., Martinez A., Mazorra Z., Meriño E., Ortega L.M., Ramírez A., Ramos M., Saavedra Hernández D., Sánchez L., Sánchez N., Tania Crombet, Valenzuela-Silva C.M.Fuentes:scopusUse of a Humanized Anti-CD6 Monoclonal Antibody (Itolizumab) in Elderly Patients with Moderate COVID-19
ArticleAbstract: Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a recent outbreaPalabras claves:Autores:Caballero A., Calderón N.A., Cepeda M., Diáz Y., Estevez D., Hidalgo C.J., La O Y., Leon K., Lorenzo G., Luaces P.L.o., Martín Y., Mazorra Z., Oyarzábal J.P.A., Pérez Y., Ramos-Suzarte M., Saavedra Hernández D., Santiago W., Tania Crombet, Valenzuela-Silva C.M., Viñet O.Fuentes:scopusSafety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults
ArticleAbstract: Background: SOBERANA 02 has been evaluated in phase I and IIa studies comparing homologous versus hePalabras claves:Conjugate vaccine, covid-19, heterologous schedule, phase IIb clinical trial, recombinant RBD, Translation to patientsAutores:Acevedo-Martínez Y., Acosta-Martinez M.A., Alfaro-Guzmán A., Amoroto M., Arteaga-García A., Ávila-Cabreja J.A., Baro-Roman G., Bergado-Baez G., Biglari A., Boggiano-Ayo T., Brito-Pascual I., Cardoso-SanJorge F., Chen G.W., Climent-Ruiz Y., Coviella-Artime J.M., Cruz-Sui O., Cubas-Curbelo M., Díaz-Hernández M., Domínguez-Pentón Y.R., Doroud D., Dubed-Echevarría M., Enriquez-Puertas J., Espi-Ávila J., Espino-Rojas N.T., Estoque-Cabrera S., Fernández-Castillo S., Fontanies-Fernández M., Galano-Frutos E., Garcés-Hechavarría A., García-Carmenate M., García-López E., García-Montero M., García-Rivera D., García-Vega Y., Garrido-Arteaga R., Gómez-Maceo Y., González-Mugica R., Guillén-Obregón B., Hernández-Garcia T., Lora-García J., Martínez-Bedoya D., Martínez-Pérez M., Martínez-Rivera R., Medina-Nápoles M., Medinas-Santos G.M., Mendoza-Hernández I., Misladys Rodríguez Ortega, Morales-Ruano S., Morffi-Cinta I., Muñoz Y., Noa-Romero E., Ojito-Magaz E., Ontivero-Pino I., Orosa-Vázquez I., Palenzuela-Diaz A., Paredes-Moreno B., Pérez-Guevara M.T., Perez-Perez A., Pérez-Rodríguez S., Pi-Estopiñán F., Quintero-Moreno L., Ramírez-Gonzalez U., Reyes-Matienzo R., Rivera D.G., Rodríguez-Castillo P.G., Rodriguez-González M., Rodríguez-Noda L., Sanchez-Ramirez B., Santana-Mederos D., Santos-Vega B.L., Sarda-Rodriguez I.L., Toledo-Romani M.E., Valdes-Balbín Y., Valenzuela-Silva C.M., Valera-Fernández R., Verdecia-Sánchez L., Verez-Bencomo V., Zulueta-Pérez L.Fuentes:scopusRecombinant gamma interferon for the treatment of pulmonary and mycobacterial diseases
ArticleAbstract: An increased antibiotic resistance is described for Mycobacterium tuberculosis and atypical mycobactPalabras claves:BCG, Idiopathic pulmonary fibrosis, Interferon gamma, Lymphadenitis, Multidrug-resistant pulmonary tuberculosis, Mycobacteria, Mycobacterium avium complexAutores:Abreu G., Cayón I., García I., González-Méndez L., Jiménez G., López P., Milanés M.T., Sánchez R.B., Santos Y., Thelvia I. Ramos Gómez, Valdés M., Valenzuela-Silva C.M.Fuentes:googlescopus